Your post looks very similar to the one you wrote in 2012 when the share price was over $3.00. Then you were looking for a share price "well over $30. Now with the share price below .30 you look for a price over $50. Really?
NukeJohn Tuesday, 10/23/12 09:44:18 PM
Re: None
Post # of 20817
One of my biggest concerns is a hostile takeover attempt.
With the stock now in the 3's, my fear is that a big Tobacco company or, more likely, a big Pharma company, could attempt a hostile takeover at an unrealistically low price. I have spent about ten years following this company (which I believe one day will be well above $30/share as the benefits of Anatabloc become known). I would hate to see a deep pocketed pharma company come along and offer $7-10. Even if forced to up the offer to $15 or more, that is still not a realistic price considering the huge potential of Anatabloc. I believe a lowball offer like this would be heavily opposed by management. But, it's entirely possible that a large number of shareholders who bought in for $2-3 might accept a tender offer below $20. While I completely understand that a lot of people would be happy getting $20 for their stock....I definitely would not, as my target selling price is much higher.
I think we should be paying close attention to the volume and price action over the coming weeks. If we see heavy accumulation, we should be on the lookout for Form 13-D filings. Once a company planning a takeover reaches a holding above 5%, they must file a Form-13D within 10 days.
IMHO, the sooner the details of the clinical trials and all the details of the RJR agreements become public, the less likely it will be for a hostile takeover to be successful.
JMHO,
